April 2012

Recipients of 2012 SAFE-Biopharma Digi Award named

Monday, April 30, 2012

Recipients have been selected for the 2012 SAFE-BioPharma Digi Award, recognizing innovative uses of the global SAFE-BioPharma digital identity and digital signature standard and the institutions and individuals contributing to broader understanding of its benefits. Recipients included: Astellas, Bristol-Myers Squibb and representatives of two U.S. government entities.

[Read More]

Almac rewarded for excellence in technology

Monday, April 30, 2012

Service provider Almac has been recognized for its technological developments, scooping a top award at the recent Belfast Telegraph Northern Ireland Business Awards 2012, in association with British Midland International (BMI).

[Read More]

FDA approves Stendra for ED

Monday, April 30, 2012

The FDA has approved Stendra (avanafil) tablets for the treatment of erectile dysfunction (ED), marking the first new prescription agent approved in nearly a decade for the condition that afflicts as many as 30 million men in the U.S., according to biopharmaceutical company Vivus.

[Read More]

Pharmanest initiates phase I SHACT trial

Monday, April 30, 2012

Pharmanest, a Stockholm-based pharmaceutical company, has dosed its first patient has in an open label pharmacokinetic phase I study with its drug candidate SHACT, a product developed for pain relief in connection with intrauterine device (IUD) insertion.

[Read More]